2020
DOI: 10.1002/aoc.5610
|View full text |Cite
|
Sign up to set email alerts
|

Co(III) N,N′‐diarylformamidine dithiocarbamate complexes: Synthesis, characterization, crystal structures and biological studies

Abstract: Three symmetric N,N‐diarylformamidine dithiocarbamates, N,N′‐bis(2,6‐dimethylphenyl)formamidine dithiocarbamate (DTL1), N,N′‐bis(2,6‐disopropylphenyl)formamidine dithiocarbamate (DTL2) and N,N′‐dimesitylformamidine dithiocarbamate (DTL3), and three unsymmetric ones, N′‐(2,6‐dichlorophenyl‐N‐(2,6‐dimethylphenyl)formamidine dithiocarbamate (DTL4), N′‐(2,6‐dichlorophenyl)‐N‐(2,6‐diisopropylphenyl)formamidine dithiocarbamate (DTL5) and N′‐(2,6‐dichlorophenyl)‐N‐mesitylformamidine dithiocarbamate (DLT6), were react… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
21
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 31 publications
(23 citation statements)
references
References 87 publications
2
21
0
Order By: Relevance
“…Earlier, Cu compounds used as therapeutic agents suffered some drawbacks, , such as solubility issues, which could be solved as recently proposed by Wehbe et al However, Cu-based complexes have resurfaced lately in inorganic synthesis investigations with rapt attention in which researchers have prepared Cu complexes for various medical indications. , For instance, Cu­(II)–indomethacin complexes have found application in veterinary science as anti-inflammatory medicine. , This re-emergence is partly inherent from copper’s existence in many natural biological pathways that could control Cu levels and metabolize it appreciably …”
Section: Introductionmentioning
confidence: 99%
“…Earlier, Cu compounds used as therapeutic agents suffered some drawbacks, , such as solubility issues, which could be solved as recently proposed by Wehbe et al However, Cu-based complexes have resurfaced lately in inorganic synthesis investigations with rapt attention in which researchers have prepared Cu complexes for various medical indications. , For instance, Cu­(II)–indomethacin complexes have found application in veterinary science as anti-inflammatory medicine. , This re-emergence is partly inherent from copper’s existence in many natural biological pathways that could control Cu levels and metabolize it appreciably …”
Section: Introductionmentioning
confidence: 99%
“…The spectroscopic characterization of the compounds, being rather sparse in the literature, has been performed for all the compounds described in the paper and it is detailed in the Experimental section. The IR spectra (solid state) display an absorption assigned to the {CS 2 } moiety in the range 984–949 cm −1 , [31] while the thioureide {N−CS 2 } carbon‐nitrogen bond stretching is observed in the interval 1526–1479 cm −1 , suggesting a bond order in between a single (1350–1250 cm −1 ) and a double one (1690–1640 cm −1 ) [32,33] . Resonances around 210 ppm due to the {CS 2 } carbon are observed in the 13 C NMR spectra (in CDCl 3 ).…”
Section: Resultsmentioning
confidence: 96%
“…Note that cyclic dithiocarbamates are isomers of dithiolanes and their {SC=S} group is typically featured by a 13 C resonance at ca. 200 ppm, [32–36] whereas a diagnostic signal was found around 165 ppm in products spectra and assigned to the C=N moiety of dithiolanes [9,16] . All the IR spectra of prepared 2‐amino‐1,3‐dithiolanes display an intense absorption from 1590 to 1605 cm −1 due to the C=N stretching.…”
Section: Resultsmentioning
confidence: 97%
“…With the CS 2 moieties added on, a propeller like core is formed (Figure 2c). In the electronic spectra of 1 and 2, two bands were observed at 238 and 312, and 314 nm and these are attributed to intraligand π→π* transition associated with N-C=S and π→π* transition within S-C=S groups of the coordinated dithiocarbamate ligands [37].…”
Section: X-ray Structural Analysismentioning
confidence: 99%